Showing 1 - 9 results of 9 for search 'Lishu Zhao', 查询时间: 0.05s Refine Results
  1. 1
    Downregulation of miR-574-5p inhibits HK-2 cell viability and predicts the onset of acute kidney injury in sepsis patients

    Downregulation of miR-574-5p inhibits HK-2 cell viability and predicts the onset of acute kidney injury in sepsis patients 由 Shanshan Liu, Lishu Zhao, Li Zhang, Lujun Qiao, Shufang Gao

    出版 2021-01-01
    获取全文
    文件
  2. 2
    Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications

    Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications 由 Lishu Zhao, Hao Wang, Kandi Xu, Xinyue Liu, Yayi He, Peifang Wei

    出版 2022-05-01
    获取全文
    文件
  3. 3
    Efficacy of Naprapathy in Brachial Plexus Injury: Protocol for a Randomized Clinical Trial

    Efficacy of Naprapathy in Brachial Plexus Injury: Protocol for a Randomized Clinical Trial 由 Bin Xiao, Lishu Zhao, Yong Huang, Anqi Ma, Baoshun Pei, Zhengyu Li, Fei Gu

    出版 2023-05-01
    获取全文
    文件
  4. 4
    Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment

    Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment 由 Peixin Chen, Peixin Chen, Hao Wang, Hao Wang, Lishu Zhao, Lishu Zhao, Haoyue Guo, Haoyue Guo, Liping Zhang, Wei Zhang, Chenglong Sun, Chenglong Sun, Sha Zhao, Sha Zhao, Wei Li, Wei Li, Jun Zhu, Jun Zhu, Jia Yu, Jia Yu, Chunyan Wu, Yayi He, Yayi He

    出版 2021-11-01
    获取全文
    文件
  5. 5
    Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancer

    Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancer 由 Xinyue Liu, Yan Kong, Youwen Qian, Haoyue Guo, Lishu Zhao, Hao Wang, Kandi Xu, Li Ye, Yujin Liu, Hui Lu, Yayi He

    出版 2024-12-01
    获取全文
    文件
  6. 6
    Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer

    Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer 由 Jun Zhu, Hao Wang, Wei Li, Wei Zhang, Liping Zhang, Caicun Zhou, Peixin Chen, Chenglong Sun, Chunyan Wu, Yayi He, Jia Yu, Lishu Zhao, Sha Zhao

    出版 2021-08-01
    获取全文
    文件
  7. 7
    Correction: T follicular helper cells: linking cancer immunotherapy and immune-related adverse events

    Correction: T follicular helper cells: linking cancer immunotherapy and immune-related adverse events 由 Jun Zhu, Hao Wang, Wei Li, Wei Zhang, Liping Zhang, Caicun Zhou, Peixin Chen, Chenglong Sun, Chunyan Wu, Yayi He, Jia Yu, Lishu Zhao, Sha Zhao

    出版 2021-08-01
    获取全文
    文件
  8. 8
    Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1

    Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1 由 Lishu Zhao, Jianxian Ge, Ruru Zhang, Hao Wang, Xinyue Liu, Kandi Xu, Yujin Liu, Wencheng Zhao, Wengang Zhang, Li Ye, Zhimin Chen, Jianfeng Zeng, Yayi He, Mingyuan Gao

    出版 2025-01-01
    获取全文
    文件
  9. 9
    What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation: a systematic review and network meta-analysis

    What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation: a systematic review and network meta-analysi... 由 Wengang Zhang, Xinyu Zhang, Wencheng Zhao, Zhiyi Guo, Xinyue Liu, Li Ye, Zhimin Chen, Kandi Xu, Yujin Liu, Hao Wang, Lishu Zhao, Qianqian Zhang, Yujie Li, Xuyang Chen, Yayi He

    出版 2024-12-01
    获取全文
    文件

检索工具: